News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 150
- Sources here
- 16
- Companies here
- 9
Search results
Stored financial headlines
Active search
150 matching headlines
Ticker or company: DRUGMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Bright Minds Biosciences (NASDAQ:DRUG) Shares Up 5% - Should You Buy?
Bright Minds Biosciences (NASDAQ:DRUG) shares increased by 5% on Friday, reaching $79.16 with below-average trading volume. The company has a "Moderate Buy" consensus rating from analysts with an average price target of $143.83, and recently surpassed EPS estimates. Insider and institutional ownership remains significant, …
DRUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +73.9% · Next-week setup negative 43.1%